Terumo (OTCMKTS:TRUMY) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Terumo (OTCMKTS:TRUMY) released its quarterly earnings data on Friday. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.13, Zacks reports. Terumo had a return on equity of 9.17% and a net margin of 12.09%.

Terumo Trading Up 9.0%

Shares of TRUMY stock traded up $1.31 on Friday, hitting $15.85. The company had a trading volume of 56,969 shares, compared to its average volume of 287,964. Terumo has a twelve month low of $12.08 and a twelve month high of $19.60. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59. The firm has a market cap of $23.38 billion, a P/E ratio of 25.98 and a beta of 0.68. The stock’s 50-day moving average is $13.98 and its two-hundred day moving average is $13.54.

Analyst Upgrades and Downgrades

TRUMY has been the topic of several recent research reports. Zacks Research upgraded shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Terumo has a consensus rating of “Buy”.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.